vs

Side-by-side financial comparison of Hippo Holdings Inc. (HIPO) and Liquidia Corp (LQDA). Click either name above to swap in a different company.

Hippo Holdings Inc. is the larger business by last-quarter revenue ($120.4M vs $92.0M, roughly 1.3× Liquidia Corp). Liquidia Corp runs the higher net margin — 15.8% vs 5.0%, a 10.8% gap on every dollar of revenue. On growth, Liquidia Corp posted the faster year-over-year revenue change (3054.6% vs 18.2%). Liquidia Corp produced more free cash flow last quarter ($42.2M vs $9.1M).

Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.

Liquidia Corp is a late-stage biopharmaceutical firm focused on developing and commercializing innovative inhaled therapies for respiratory and rare diseases. It uses its proprietary PRINT particle engineering tech to create optimized drug products, with core markets in North America covering pulmonary arterial hypertension and asthma indications.

HIPO vs LQDA — Head-to-Head

Bigger by revenue
HIPO
HIPO
1.3× larger
HIPO
$120.4M
$92.0M
LQDA
Growing faster (revenue YoY)
LQDA
LQDA
+3036.5% gap
LQDA
3054.6%
18.2%
HIPO
Higher net margin
LQDA
LQDA
10.8% more per $
LQDA
15.8%
5.0%
HIPO
More free cash flow
LQDA
LQDA
$33.1M more FCF
LQDA
$42.2M
$9.1M
HIPO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIPO
HIPO
LQDA
LQDA
Revenue
$120.4M
$92.0M
Net Profit
$6.0M
$14.6M
Gross Margin
Operating Margin
5.6%
21.5%
Net Margin
5.0%
15.8%
Revenue YoY
18.2%
3054.6%
Net Profit YoY
-86.4%
137.9%
EPS (diluted)
$0.31
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIPO
HIPO
LQDA
LQDA
Q4 25
$120.4M
$92.0M
Q3 25
$120.6M
$54.3M
Q2 25
$117.3M
Q1 25
$110.3M
Q4 24
$101.9M
Q3 24
$95.5M
Q2 24
$89.6M
Q1 24
$85.1M
Net Profit
HIPO
HIPO
LQDA
LQDA
Q4 25
$6.0M
$14.6M
Q3 25
$98.1M
$-3.5M
Q2 25
$1.3M
Q1 25
$-47.7M
Q4 24
$44.2M
Q3 24
$-8.5M
Q2 24
$-40.5M
Q1 24
$-35.7M
Operating Margin
HIPO
HIPO
LQDA
LQDA
Q4 25
5.6%
21.5%
Q3 25
81.3%
3.3%
Q2 25
3.4%
Q1 25
-41.3%
Q4 24
46.3%
Q3 24
-5.4%
Q2 24
-40.7%
Q1 24
-38.7%
Net Margin
HIPO
HIPO
LQDA
LQDA
Q4 25
5.0%
15.8%
Q3 25
81.3%
-6.5%
Q2 25
1.1%
Q1 25
-43.2%
Q4 24
43.4%
Q3 24
-8.9%
Q2 24
-45.2%
Q1 24
-42.0%
EPS (diluted)
HIPO
HIPO
LQDA
LQDA
Q4 25
$0.31
$0.18
Q3 25
$3.77
$-0.04
Q2 25
$0.05
Q1 25
$-1.91
Q4 24
$1.81
Q3 24
$-0.34
Q2 24
$-1.64
Q1 24
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIPO
HIPO
LQDA
LQDA
Cash + ST InvestmentsLiquidity on hand
$218.3M
$190.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$436.1M
$44.7M
Total Assets
$1.9B
$327.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIPO
HIPO
LQDA
LQDA
Q4 25
$218.3M
$190.7M
Q3 25
$247.7M
$157.5M
Q2 25
$198.9M
Q1 25
$140.9M
Q4 24
$197.6M
Q3 24
$191.2M
Q2 24
$175.9M
Q1 24
$223.4M
Stockholders' Equity
HIPO
HIPO
LQDA
LQDA
Q4 25
$436.1M
$44.7M
Q3 25
$421.5M
$22.1M
Q2 25
$332.5M
Q1 25
$322.8M
Q4 24
$362.1M
Q3 24
$326.4M
Q2 24
$322.6M
Q1 24
$351.2M
Total Assets
HIPO
HIPO
LQDA
LQDA
Q4 25
$1.9B
$327.9M
Q3 25
$1.9B
$276.0M
Q2 25
$1.7B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIPO
HIPO
LQDA
LQDA
Operating Cash FlowLast quarter
$9.2M
$44.2M
Free Cash FlowOCF − Capex
$9.1M
$42.2M
FCF MarginFCF / Revenue
7.6%
45.9%
Capex IntensityCapex / Revenue
0.1%
2.2%
Cash ConversionOCF / Net Profit
1.53×
3.04×
TTM Free Cash FlowTrailing 4 quarters
$14.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIPO
HIPO
LQDA
LQDA
Q4 25
$9.2M
$44.2M
Q3 25
$16.9M
$-9.8M
Q2 25
$24.7M
Q1 25
$-35.6M
Q4 24
$47.5M
Q3 24
$46.8M
Q2 24
$-10.6M
Q1 24
$17.7M
Free Cash Flow
HIPO
HIPO
LQDA
LQDA
Q4 25
$9.1M
$42.2M
Q3 25
$16.8M
$-10.7M
Q2 25
$24.6M
Q1 25
$-35.7M
Q4 24
$47.2M
Q3 24
Q2 24
$-10.7M
Q1 24
$17.6M
FCF Margin
HIPO
HIPO
LQDA
LQDA
Q4 25
7.6%
45.9%
Q3 25
13.9%
-19.7%
Q2 25
21.0%
Q1 25
-32.4%
Q4 24
46.3%
Q3 24
Q2 24
-11.9%
Q1 24
20.7%
Capex Intensity
HIPO
HIPO
LQDA
LQDA
Q4 25
0.1%
2.2%
Q3 25
0.1%
1.7%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.3%
Q3 24
0.0%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
HIPO
HIPO
LQDA
LQDA
Q4 25
1.53×
3.04×
Q3 25
0.17×
Q2 25
19.00×
Q1 25
Q4 24
1.07×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons